Our focus areas
Welcome to the core of our business. Pharmaceutical companies, biotechs and research institutions can see three key areas where Quayside Research excels, where we can offer our experience and commitment to improving clinical trial methodology.
Our expertise
At Quayside Research, we focus on three core disease areas, where we can make valuable contributions to research projects.
Chronic liver disease
Liver fibrosis and cirrhosis, whether caused by alcohol, metabolic diseases or viral hepatitis remain a huge medical challenge.
New approaches for tackling the causes and complications are being investigated.
Viral hepatitis
Curative antiviral treatments for chronic viral hepatitis B and D are still awaited despite intensive efforts of the pharma industry.
Both immunomodulatory and direct-acting antiviral approaches are required.
Arbovirus infections
Mosquito-borne viral infections threaten increasing numbers of people as Aedes mosquitoes expand their territory.
There is an urgent need for antiviral treatments and appropriate clinical trial methodology.
Clinical trial methodology
We have a long track record of developing new trial methodology in different diseases, and are strong believers in cross-fertilisation across therapeutic areas.
Why choose Quayside Research?
Quayside Research has the experience needed to deal with the complexities of clinical research in challenging disease areas.
Dedicated support
We offer a range of specialised services tailored to meet your individual needs. Our approach is focused on understanding and responding to what you require, providing effective and practical solutions.
Let's discuss your needs
Your projects in our focus areas may benefit from our involvement. Contact us today to discuss your specific requirements and discover how Quayside Research can help you achieve your clinical research goals.
